Literature DB >> 21994943

Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734.

Andreas Wortmann1, Yaowu He, Melinda E Christensen, Mayla Linn, John W Lumley, Pamela M Pollock, Nigel J Waterhouse, John D Hooper.   

Abstract

Reciprocal interactions between Src family kinases (SFKs) and focal adhesion kinase (FAK) are critical during changes in cell attachment. Recently it has been recognized that another SFK substrate, CUB-domain-containing protein 1 (CDCP1), is differentially phosphorylated during these events. However, the molecular processes underlying SFK-mediated phosphorylation of CDCP1 are poorly understood. Here we identify a novel mechanism in which FAK tyrosine 861 and CDCP1-Tyr-734 compete as SFK substrates and demonstrate cellular settings in which SFKs switch between these sites. Our results show that stable CDCP1 expression induces robust SFK-mediated phosphorylation of CDCP1-Tyr-734 with concomitant loss of p-FAK-Tyr-861 in adherent HeLa cells. SFK substrate switching in these cells is dependent on the level of expression of CDCP1 and is also dependent on CDCP1-Tyr-734 but is independent of CDCP1-Tyr-743 and -Tyr-762. In HeLa CDCP1 cells, engagement of SFKs with CDCP1 is accompanied by an increase in phosphorylation of Src-Tyr-416 and a change in cell morphology to a fibroblastic appearance dependent on CDCP1-Tyr-734. SFK switching between FAK-Tyr-861 and CDCP1-Tyr-734 also occurs during changes in adhesion of colorectal cancer cell lines endogenously expressing these two proteins. Consistently, increased p-FAK-Tyr-861 levels and a more epithelial morphology are seen in colon cancer SW480 cells silenced for CDCP1. Unlike protein kinase Cδ, FAK does not appear to form a trimeric complex with Src and CDCP1. These data demonstrate novel aspects of the dynamics of SFK-mediated cell signaling that may be relevant during cancer progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21994943      PMCID: PMC3234987          DOI: 10.1074/jbc.M111.227462

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397.

Authors:  Abdelkader Hamadi; Maya Bouali; Monique Dontenwill; Herrade Stoeckel; Kenneth Takeda; Philippe Rondé
Journal:  J Cell Sci       Date:  2005-09-13       Impact factor: 5.285

2.  The C2 domain of PKCdelta is a phosphotyrosine binding domain.

Authors:  Cyril H Benes; Ning Wu; Andrew E H Elia; Tejal Dharia; Lewis C Cantley; Stephen P Soltoff
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

Review 3.  Cellular functions regulated by Src family kinases.

Authors:  S M Thomas; J S Brugge
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

4.  Adhesion signaling by a novel mitotic substrate of src kinases.

Authors:  Ami S Bhatt; Hediye Erdjument-Bromage; Paul Tempst; Charles S Craik; Mark M Moasser
Journal:  Oncogene       Date:  2005-08-11       Impact factor: 9.867

5.  Epigenetic regulation of the expression of the novel stem cell marker CDCP1 in cancer cells.

Authors:  J-i Ikeda; E Morii; H Kimura; Y Tomita; T Takakuwa; J-i Hasegawa; Y-K Kim; Y Miyoshi; S Noguchi; T Nishida; K Aozasa
Journal:  J Pathol       Date:  2006-09       Impact factor: 7.996

6.  SH2- and SH3-mediated interactions between focal adhesion kinase and Src.

Authors:  J W Thomas; B Ellis; R J Boerner; W B Knight; G C White; M D Schaller
Journal:  J Biol Chem       Date:  1998-01-02       Impact factor: 5.157

7.  Proteolysis-induced N-terminal ectodomain shedding of the integral membrane glycoprotein CUB domain-containing protein 1 (CDCP1) is accompanied by tyrosine phosphorylation of its C-terminal domain and recruitment of Src and PKCdelta.

Authors:  Yaowu He; Andreas Wortmann; Les J Burke; Janet C Reid; Mark N Adams; Ibtissam Abdul-Jabbar; James P Quigley; Richard Leduc; Daniel Kirchhofer; John D Hooper
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

8.  Focal adhesion kinase tyrosine-861 is a major site of phosphorylation by Src.

Authors:  M B Calalb; X Zhang; T R Polte; S K Hanks
Journal:  Biochem Biophys Res Commun       Date:  1996-11-21       Impact factor: 3.575

9.  Activating SRC mutation in a subset of advanced human colon cancers.

Authors:  R B Irby; W Mao; D Coppola; J Kang; J M Loubeau; W Trudeau; R Karl; D J Fujita; R Jove; T J Yeatman
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

Review 10.  The role of focal-adhesion kinase in cancer - a new therapeutic opportunity.

Authors:  Gordon W McLean; Neil O Carragher; Egle Avizienyte; Jeff Evans; Valerie G Brunton; Margaret C Frame
Journal:  Nat Rev Cancer       Date:  2005-07       Impact factor: 60.716

View more
  21 in total

1.  CDCP1 cleavage is necessary for homodimerization-induced migration of triple-negative breast cancer.

Authors:  H J Wright; J Arulmoli; M Motazedi; L J Nelson; F S Heinemann; L A Flanagan; O V Razorenova
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

2.  The cell surface glycoprotein CUB domain-containing protein 1 (CDCP1) contributes to epidermal growth factor receptor-mediated cell migration.

Authors:  Ying Dong; Yaowu He; Leonore de Boer; M Sharon Stack; John W Lumley; Judith A Clements; John D Hooper
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

3.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

4.  Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.

Authors:  Y He; A C Wu; B S Harrington; C M Davies; S J Wallace; M N Adams; J S Palmer; D K Roche; B G Hollier; T F Westbrook; H Hamidi; G E Konecny; B Winterhoff; N P Chetty; A J Crandon; N B Oliveira; C M Shannon; A V Tinker; C B Gilks; J I Coward; J W Lumley; L C Perrin; J E Armes; J D Hooper
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

5.  Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms.

Authors:  M E Law; P E Corsino; S C Jahn; B J Davis; S Chen; B Patel; K Pham; J Lu; B Sheppard; P Nørgaard; J Hong; P Higgins; J-S Kim; H Luesch; B K Law
Journal:  Oncogene       Date:  2012-04-30       Impact factor: 9.867

6.  Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca2+ entry regulates disassembly of adherens junctions.

Authors:  Dheeraj Soni; Sushil C Regmi; Dong-Mei Wang; Auditi DebRoy; You-Yang Zhao; Stephen M Vogel; Asrar B Malik; Chinnaswamy Tiruppathi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-04-06       Impact factor: 5.464

7.  Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells.

Authors:  B Casar; Y He; M Iconomou; J D Hooper; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2011-12-19       Impact factor: 9.867

8.  In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling.

Authors:  B Casar; I Rimann; H Kato; S J Shattil; J P Quigley; E I Deryugina
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

9.  CD318 is a ligand for CD6.

Authors:  Gospel Enyindah-Asonye; Yan Li; Jeffrey H Ruth; Danislav S Spassov; Katie E Hebron; Andries Zijlstra; Mark M Moasser; Benlian Wang; Nora G Singer; Huadong Cui; Ray A Ohara; Stephanie M Rasmussen; David A Fox; Feng Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-31       Impact factor: 11.205

10.  CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin.

Authors:  Yaowu He; Claire M Davies; Brittney S Harrington; Linh Hellmers; Yonghua Sheng; Amy Broomfield; Thomas McGann; Kate Bastick; Laurie Zhong; Andy Wu; Grace Maresh; Shannon McChesney; Kuan Yau Wong; Mark N Adams; Ryan C Sullivan; James S Palmer; Lez J Burke; Adam D Ewing; Xin Zhang; David Margolin; Li Li; Rohan Lourie; Admire Matsika; Bhuvana Srinivasan; Michael A McGuckin; John W Lumley; John D Hooper
Journal:  Oncogene       Date:  2019-08-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.